{name}
{subtitle}
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
city
~9 mi. (Gdynia, Poland, +158 more cities)
facility
Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 2400)
drug
olaparib, +4 more drugs
drug type
chemotherapy, +3 more types
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~9 mi. (Gdynia, Poland, +150 more cities)
facility
Szpitale Pomorskie Sp. z o.o. ( Site 0935)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)
city
~9 mi. (Gdynia, Poland, +127 more cities)
facility
Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 2504)
drug
lenvatinib, +1 more drug
drug type
immunotherapy, +1 more type
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
city
~9 mi. (Gdynia, Poland, +44 more cities)
facility
Szpitale pomorskie gdynia dept of haematology
biomarker
BCL2 Fusion, +2 more biomarkers
condition
Diffuse Large B-Cell Lymphoma, +3 more conditions
drug
cisplatin, +5 more drugs
drug type
chemotherapy, +3 more types
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~25 mi. (Gdańsk, Poland, +199 more cities)
facility
Copernicus PL Sp. z o.o. ( Site 0603)
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
city
~25 mi. (Gdańsk, Poland, +137 more cities)
facility
Uniwersyteckie Centrum Kliniczne-Klinka Chirurgii Onkologicznej ( Site 0960)
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~25 mi. (Gdańsk, Poland, +201 more cities)
facility
Uniwersyteckie Centrum Kliniczne /ID# 222069
drug
azacitidine, +1 more drug
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)
city
~25 mi. (Gdańsk, Poland, +115 more cities)
facility
Uniwersyteckie Centrum Kliniczne ( Site 1809)
biomarker
ATM Loss, +27 more biomarkers
condition
Breast Carcinoma, +2 more conditions
drug
olaparib, +1 more drug
drug type
immunotherapy, +1 more type